Case of The Month #40 – PSOGI
PSOGI(Peritoneal Surface Oncology Group International) shared a post on LinkedIn:
“PSOGICASE
CASE OF THE MONTH #40Summarized here
Management of symptomatic, MSI-H colorectal peritoneal metastases
With Paul Sugarbaker and Peter CashinEvidence is evolving in favour of non-surgical treatment of MSI-H tumors. But do we have all the answers yet
- Are there any indications for surgery in MSI-H CPM
- What drug (s) to be used and when?
- Immunotherapy for symptomatic patients
- Response assessment- when, how
- Management of progression on immunotherapy
We are the happiest when medical oncologists evesdrop on the dicussion.
Thanks Pashtoon Kasi for your inputs.
Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair deficient metastatic colorectal cancer
Authors: Pashtoon Murtaza Kasi, Griffin Budde, Michael Krainock, Vasily N Aushev, Allyson Koyen Malashevich, Meenakshi Malhotra, Perry Olshan, Paul R Billings and Alexey Aleshin
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023